Screening for Chronic Obstructive Pulmonary Disease
Interview with William R. Phillips, MD, MPH, author of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement
Interview with William R. Phillips, MD, MPH, author of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement
Interview with Alex H. Krist, MD, MPH, Task Force member and co-author of Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement
Interview with Anthony S. Fauci, MD, author of Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles
Jury chose HDFC Bank MD for his contribution in digital banking, the bank's presence in rural and semi-urban India and healthy profitability
With the emergence of coronavirus disease 2019 (COVID-19) as a global pandemic, individuals with preexisting chronic health conditions such as hypertension, diabetes, and cardiovascular disease have been identified as particularly vulnerable. These patients are also more likely than the general population to be taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that causes COVID-19 gains entry into cells via binding to the angiotensin-converting enzyme 2 (ACE2) receptor, concerns have been raised that these therapies might facilitate the transmission of the virus or affect outcomes adversely. Given that ACEI and ARB therapies are known to provide benefit for the underlying conditions treated, stopping ACEI/ARB therapy carries risks. Moreover, local inactivation of the renin-angiotensin-aldosterone system may have protective effects against the development and progression of acute lung failure. In the absence of clinical evidence of benefit or risk of ACEIs/ARBs, current societal statements recommend against discontinuing these drugs other than for standard clinical indications. Robust clinical data are needed to clarify the effect of ACEIs/ARBs on SARS-CoV-2 infection.
Autor:
Erschienen 1870
BSB-Signatur Cbm Cat. 805(1 b 29
URN: urn:nbn:de:bvb:12-bsb00131477-4
URL: http://daten.digitale-sammlungen.de/~db/0013/bsb00131477/images/
Forbes & Company, a Shapoorji Pallonji group firm on Tuesday announced plans to list its subsidiary Eureka Forbes to unlock value for shareholders. The company's board has authorised the management to evaluate any such scheme in this regard, Forbes & Company said in a regulatory filing. "The Board of Directors of the company has authorised the management...to evaluate a scheme of arrangement and/or other appropriate mechanisms to enable an eventual listing of Eureka Forbes with an intention to unlock value in the hands of all the shareholders of the company," it said. These may also include listing, dilution/sale or combination thereof of Eureka Forbes, it added. Eureka Forbes is a wholly-owned subsidiary of Forbes & Company. "The Board will consider the above (schemes) when the relevant proposals are placed before it in the near future, but in principle has approved supporting the endeavours of the management in this regard," it said. It operates in water purifier, air ...
The company, which aims to raise up to Rs 410 crore, has fixed a price of Rs 193-195 per share for the IPO.
Siddharth Purohit of SMC Global Securities believes that given the stable RoE of 30% valuation, in terms of P/E ratio is likely to come down to 31x and 22x in FY21 and FY22, respectively from 43x.
The IPO comprises a fresh issue of Rs 500 crore and an offer for sale of 13,05,26,798 equity shares
At the top-end, the stock is valued at 46x its earnings for the first nine months of 2019-20.
Flights from Kolkata are unlikely to take off right after the lockdown on flights is lifted. Sources in the civil aviation industry indicated that flights post lockdown would initially operate between smaller airports to ensure regional connectivity between tier-III towns, which are in the green zone. It is only thereafter that airports in tier-II cities in the orange zone and finally, those in metro cities, including Kolkata, that are in the red zone, will start operations.